Net proceeds from convertible notes offering
Company: Core Scientific
The claim, verbatim
Net proceeds estimated at approximately $608.7 million after deducting initial purchasers' discounts, commissions and offering expenses
Source (primary)
Core Scientific 424B3 filed 2024-12-06 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “The Company estimates that the net proceeds from the Offering will be approximately $608.7 million, after deducting the initial purchasers' discounts and commissions and the Company's estimated offering expenses.”
How we checked this
Checked on September 17, 2026. The cited source supports every part of this claim.
The filing gives the $608.7 million net proceeds estimate with these same deductions.
Confirmed in the source:
- Net proceeds from the offering are estimated at approximately $608.7 million
- The estimate is after deducting initial purchasers' discounts and commissions and estimated offering expenses
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000162828024050176/prospectussupplement120220.htm) in full (17,724 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2024-12-06
Quote: “The Company estimates that the net proceeds from the Offering will be approximately $608.7 million, after deducting the initial purchasers' discounts and commissions and the Company's estimated offering expenses.”